<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Decreased survival with sotalol in the SWORD trial</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Decreased survival with sotalol in the SWORD trial</h1>
<div class="graphic"><div class="figure"><div class="ttl">Decreased survival with sotalol in the SWORD trial</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Results from the Survival With Oral d-Sotalol (SWORD) trial. The administration of d-sotalol to patients with an ejection fraction ≤40 percent after either recent myocardial infarction (MI) or after symptomatic heart failure with a remote (&gt;42 days) MI was associated with increased mortality compared with placebo (5 versus 3.1 percent). The excess number of deaths was presumed to be primarily due to arrhythmias.</div><div class="graphic_reference">Data from: Waldo AL, Camm AJ, DeRuyter H, et al. Lancet 1996; 348:7.</div><div id="graphicVersion">Graphic 71934 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
